Phase III and data should be made available this year. Listen to Dr. Berk in his latest conference, he hinted soon. That indicates, sometime this year...and from my understand...Dacogen works best in the advance stages of this cancer. This would probably mean once Vidaza patients crossed over to AML. Dacogen would be the only compound approved for AML and with 50% of MDS patients not taking any of these drugs, well doctors would have to serious look at Dacogen once their patients reached this progression.